What chemotherapy regimen would you recommend for high risk ER+/Her2- LN negative breast cancer with high genomic risk disease?  

I.e. according to Mammaprint test?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Medical College of Wisconsin
Comment - For genomic risk assessment, I generally...
Sign in or Register to read more